General AML

Prof. Jeffrey E. Lancet | 2017 ASCO Annual Meeting | CPX-351 vs 7+3 in older adults with newly diagnosed, therapy-related AML (tAML)

L:

2017 ASCO Annual Meeting - 2-6 June, Chicago